Flaharty Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Flaharty Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$2.08K	–	153
2025 Q1	$2.08K	Buy	+100	New	+$2.51K	﹤0.01%	444
2024 Q4	–	Sell	-100	Closed	-$2.56K	–	148
2024 Q3	$2.56K	Buy	+100	New	+$2.55K	﹤0.01%	401
2023 Q4	–	Sell	-100	Closed	-$2.79K	–	136
2023 Q3	$2.79K	Buy	+100	New	+$3.27K	﹤0.01%	412
2021 Q4	–	Sell	-29,392	Closed	-$2.2M	–	139
2021 Q3	$2.2M	Buy	29,392 +10,451	+55%	+$877K	0.45%	31
2021 Q2	$1.75M	Buy	18,941 +9,840	+108%	+$837K	0.37%	37
2021 Q1	$807K	Buy	9,101 +6,813	+298%	+$676K	0.19%	54
2020 Q4	$213K	Buy	+2,288	New	+$182K	0.05%	99

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Flaharty Asset Management's ARKG Position: Q2 2025 in Review

Flaharty Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 100 shares — an estimated $2.08K sold.

Flaharty Asset Management first reported a position in ARKG in Q4 2020 and held it in 7 quarters. The position peaked at $2.2M in Q3 2021. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

Flaharty Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
Flaharty Asset Management sold 100 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $2.08K.
Flaharty Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 7 quarters.
Flaharty Asset Management's ARK Genomic Revolution ETF position peaked at $2.2M in Q3 2021.
213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Flaharty Asset Management's 13F filing for Q2 2025, filed 8 Aug 2025.